NHTSA Report: Alcohol and Drug Prevalence Among Seriously or Fatally Injured Road Users
About this document
- Layer
- attachment: a document a meeting packet links to
- Type as titled
- publication (kind from doc_type)
- File
- 3a0160e9792366039c4c24908c2d7e1cb47c0353 application/pdf
- Cases
About: Jaime Bermudez (case)
Toxicology Testing
The toxicology laboratory processed samples in batches as they were received from sites or the central processing laboratory. Samples that screened positive for any of the drug classes were subjected to confirmation testing. The results were recorded by blood tube ID and sent to the central database where the information was merged with the de-identified patient and crash information. No drug toxicology results were ever returned to the trauma centers or MEs, nor was participation in the study ever recorded in the trauma center or ME records.
Data Analysis Approach
The primary objective of this study was to provide a first look at drug prevalence rates among a large sample of seriously or fatally injured roadway users at selected trauma centers and MEs. The tables that follow present raw drug category prevalence rates for trauma center and ME cases separately using the drug positivity data from all sites combined across the entire study period. Additional tables in Appendix A provide drug prevalence data by individual site. The tables focus on prevalence of a given class or category of drugs as defined by this study. A person testing positive for two individual drugs that fall in the same category is only counted a single time in the drug category positivity results. A person who tested positive for more than one category of drugs is included in the counts for each separate category of drugs for which that person tested positive. Additional tables in Appendix A provide prevalence rates for individual parent drugs and metabolites.
The body of this report focuses on drug prevalence among drivers. The tables include 95% confidence intervals for each observed prevalence rate. Chi-square tests of independence and z-tests of proportions were the primary statistical analyses applied to examine associations of variables (e.g., age, sex) with the binary drug positive/negative measure for each class of drugs. The results of the statistical analyses represent observed associations within this sample from the populations of seriously or fatally injured roadway users at the study sites. No inferences should be made regarding drug prevalence rates in any other locations or for the larger populations of seriously or fatally injured roadway users across the country given the limitations of the study design.
Inactive metabolites (e.g., 11-COOH-THC, BZE, norfentanyl, EDDP), even though included in the confirmation testing, were specifically excluded from the drug-positive counts presented below unless otherwise noted. For example, cannabinoids exposure was only identified through the presence of active THC. Given the delay from time of crash to blood draw that is inherent in a study of this type, and the greatly varying times that metabolites can remain in the blood (the inactive metabolites of THC can be detected for days or even weeks after use), it is not possible to conclude from the presence of an inactive metabolite when the corresponding drug was active. The presence of an inactive metabolite indicates with assurance that the person used the drug at some time in the past. It does not, however, provide evidence the active drug was in the person's blood at the time of the crash. Therefore, the prevalence results in the body of this report focus on confirmed positives for active parent drugs or active metabolites.
The study results account for drugs administered therapeutically by EMS and the trauma centers, or other treating hospitals (if a patient was transferred to the trauma centers), between the time of the crash and the time the blood specimen was drawn. A positive drug result that could possibly be attributed to therapeutic administration (e.g., there was a record that fentanyl was given by
22
Keys: ← → or j k turn pages; / finds.